{
    "clinical_study": {
        "@rank": "18510", 
        "arm_group": [
            {
                "arm_group_label": "1", 
                "arm_group_type": "Experimental", 
                "description": "Therapeutic Contracting (TC)"
            }, 
            {
                "arm_group_label": "2", 
                "arm_group_type": "Experimental", 
                "description": "Cognitive Behavioral Coping Skills Therapy (CBT)"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate whether the community reinforcement approach (CRA)\n      plus contingency management (CM) is more effective overall than CRA only in reducing illicit\n      opioid and cocaine use during agonist maintenance treatment and at 3 and 6 month follow-up\n      after completion of study protocol, and to compare the efficacy of maintenance on\n      buprenorphine to methadone when maintenance is combined with CRA only or CRA plus CM."
        }, 
        "brief_title": "Combining Behavioral Treatment With Agonist Maintenance - 1", 
        "condition": [
            "Cocaine-Related Disorders", 
            "Opioid-Related Disorders", 
            "Substance-Related Disorders"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Opioid-Related Disorders", 
                "Cocaine-Related Disorders", 
                "Substance-Related Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Please contact site for information."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "168", 
        "firstreceived_date": "September 20, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000311", 
            "org_study_id": "NIDA-09413-1", 
            "secondary_id": "R01-09413-1"
        }, 
        "intervention": {
            "arm_group_label": [
                "1", 
                "2"
            ], 
            "description": "Experimental Therapeutic Contracting (TC)\nExperimental Cognitive Behavioral Coping Skills Therapy (CBT)", 
            "intervention_name": "Buprenorphine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Buprenorphine"
        }, 
        "lastchanged_date": "October 27, 2008", 
        "location": {
            "facility": {
                "address": {
                    "city": "New Haven", 
                    "country": "United States", 
                    "state": "Connecticut", 
                    "zip": "06519"
                }, 
                "name": "APT Residential Services Division"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Combining Behavioral Treatment With Agonist Maintenance", 
        "overall_official": {
            "affiliation": "Yale University", 
            "last_name": "Richard Schottenfeld, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 3", 
        "primary_outcome": [
            {
                "measure": "Depression"
            }, 
            {
                "measure": "Withdrawal symptoms"
            }, 
            {
                "measure": "Opioid and cocaine use"
            }, 
            {
                "measure": "Social and psychological functioning"
            }, 
            {
                "measure": "AIDS risk behavior"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000311"
        }, 
        "responsible_party": {
            "name_title": "Richard S. Schottenfeld, MD", 
            "organization": "Yale University School of Medicine"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "collaborator": {
                "agency": "Yale University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "September 1999", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2008"
    }, 
    "geocoordinates": {
        "APT Residential Services Division": "41.308 -72.928"
    }
}